Aims To estimate the health and economic burden of new and established cardiovascular
disease from 2020 to 2029 in Australia. Methods and results A two-stage multistate dynamic …

This new research report demonstrates the scale of the burden of cardiovascular disease
(CVD)-shown to be large, costly, and increasing. Whilst mortality from CVD has fallen, an …

Background For decades, the incidence and mortality of cardiovascular diseases (CVDs)
have declined. More recently, we have seen a halting in these declines, especially at …

Background Myocardial infarction (MI) remains a major health burden in Australia. Yet the
future burden of MI has not been extensively studied for the Australian population. Methods …

Background Socioeconomic status has an important effect on cardiovascular disease (CVD).
Data on the economic implications of CVD by socioeconomic status are needed to inform …

Objective To construct a whole-of-system model to inform strategies that reduce the burden
of cardiovascular disease (CVD) in Australia. Methods A system dynamics model was …

Aims To quantify how much of the coronary heart disease (CHD) mortality decline in
Northern Ireland between 1987 and 2007 could be attributed to medical and surgical …

The burden of cardiovascular disease (CVD) in the world is enormous and growing, and the
majority of those affected are in developing countries (Beaglehole and Yach 2003; Mbewu …

CVD is a major cause of morbidity and mortality worldwide, responsible for nearly a third of
all deaths. In US, 85.6 million Americans are living with CVD, including 15.5 million with …

Background—Cardiovascular disease (CVD) is the leading cause of death in the United
States and is responsible for 17% of national health expenditures. As the population ages …